AstraZeneca shares dropped sharply, erasing £14 billion from its market value, following news that senior leaders at its ...

A group of clinicians and patients has called on the government at Holyrood to adopt a “Scotland-wide focus” on chronic ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

AstraZeneca PLC on Tuesday took the rare step of addressing a sharp fall in the company's share price. Shares in the Cambridge-based pharmaceuticals company slumped 8.2% to 10,138.10 pence each in ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

Vestas Wind Systems A/S posted the largest decline among large stocks during the session, plunging 12.2%, followed by Ambu A/S Series B shares, which declined 8.7%. Shares of AstraZeneca PLC declined ...

Weighing on London, AstraZeneca fell 8.2%, losing its top spot as the most valuable company on the FTSE 100 to oil major Shell in the process. The Cambridge-based pharmaceuticals firm fell back ...

AstraZeneca showcased positive early data on three experimental weight-loss drugs at ObesityWeek, highlighting its oral GLP-1 ...

The investigation by Chinese authorities has now expanded to include the public security bureau, supervisory commission and ...

GCI Health has also announced the appointment of Dan Bunce, ex-senior director of client development at Syneos Health Communications, as EMEA head of business development. He has been tasked with ...